Acquired Company
Pfizer completed acquisition of Trillium Therapeutics on 11/17/2021 for $18.50 per share in cash, representing an aggregate purchase price of approximately $2.22 billion.
Under normal circumstances, the fund will invest at least 80% of its net assets, plus borrowings for investment purposes, in equity securities of Trillion Companies and/or financial instruments (such as swaps) that provide indirect exposure to Trillion Companies. The index tracks the performance of U.S. exchange-listed companies with market capitalizations of $1 trillion or greater (“Trillion Companies”). The fund is non-diversified. Show more
Start AI Chat
Market Cap
0.00
52 Wk Range
$19.23 - $21.27
Previous Close
$19.86
Open
$19.86
Volume
N/A
Day Range
$19.86 - $19.86
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
